Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
- Status
- TERMINATED
- Phase
- N/A
Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)
- Status
- WITHDRAWN
- Phase
- PHASE2
PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma
- Status
- COMPLETED
- Phase
- NA
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
- Status
- RECRUITING
- Phase
- N/A
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE2
EBUS-TBNA vs Flex 19G EBUS-TBNA
- Status
- COMPLETED
- Phase
- NA
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
A Study of the Safety and Efficacy of EBV Specific T-cell Lines
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
- Status
- TERMINATED
- Phase
- PHASE1
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy
- Status
- COMPLETED
- Phase
- N/A
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
- Status
- COMPLETED
- Phase
- N/A
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
- Status
- UNKNOWN
- Phase
- PHASE1
Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2